We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69B
$69B $21.59 0.75%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$50.3B
$50.3B $43.09 3.17%
HLN icon
3
Haleon
HLN
$40.4B
$40.4B $9.21 0.44%
ZTS icon
4
Zoetis
ZTS
$34.1B
$34.1B $84.03 0.25%
UTHR icon
5
United Therapeutics
UTHR
$24.9B
$24.9B $583.77 1.25%
VTRS icon
6
Viatris
VTRS
$23.8B
$23.8B $20.73 0.43%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.7B
$16.7B $165.12 1.36%
ELAN icon
8
Elanco Animal Health
ELAN
$13.3B
$13.3B $26.52 0.97%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.3B
$12.3B $14.72 0.14%
ALKS icon
10
Alkermes
ALKS
$7.88B
$7.88B $46.91 0.26%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.45B
$7.45B $94.83 1.56%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.41B
$7.41B $21.26 0.56%
LNTH icon
13
Lantheus
LNTH
$6.65B
$6.65B $101.75 0.16%
SUPN icon
14
Supernus
SUPN
$6B
$6B $28.88 2.83%
LQDA icon
15
Liquidia
LQDA
$5.1B
$5.1B $56.55 1.5%
HIMS icon
16
Hims & Hers Health
HIMS
$4.43B
$4.43B $18.89 4.26%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.65B
$3.65B $28.38 6.31%
BHC icon
18
Bausch Health
BHC
$3.18B
$3.18B $8.49 1.68%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.05B
$3.05B $16.72 0.36%
HCM icon
20
HUTCHMED
HCM
$2.56B
$2.56B $14.73 1.14%
RGC icon
21
Regencell Bioscience
RGC
$2.37B
$2.37B $4.78 3.24%
PBH icon
22
Prestige Consumer Healthcare
PBH
$2.25B
$2.25B $47.55 2.94%
PRGO icon
23
Perrigo
PRGO
$2.25B
$2.25B $16.21 0.18%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.94B
$1.94B $7.55 0.79%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.84B
$1.84B $63.80 0.2%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $372B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69B, Teva Pharmaceutical Industries (TEVA) at $50.3B and Haleon (HLN) at $40.4B.

Among institutional investors, Trulieve Cannabis (TRLV) drew the most net new fund positions in Q2 2026: 123 funds opened new positions, taking total fund holders up 121 (2,017%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.